Showing 1 - 20 results of 83 for search '(((((( 50 we decrease ) OR ( 50 026 decrease ))) OR ( 50 a decrease ))) OR ( 50 _ decrease ))~', query time: 0.58s Refine Results
  1. 1
  2. 2

    Microorganisms. by Lucas Romann (14803595)

    Published 2023
    “…Using a central venous and arterial catheter for drawing blood resulted in an increase of filling volume by 0.26 mL (95% CI 0.10, 0.41) and 0.50 mL (95% CI 0.31, 0.69) compared to peripheral venipuncture, respectively. …”
  3. 3

    Flowchart of the BCs included into this study. by Lucas Romann (14803595)

    Published 2023
    “…Using a central venous and arterial catheter for drawing blood resulted in an increase of filling volume by 0.26 mL (95% CI 0.10, 0.41) and 0.50 mL (95% CI 0.31, 0.69) compared to peripheral venipuncture, respectively. …”
  4. 4
  5. 5

    Supplementary materials. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  6. 6

    Summary of subgroup analysis results. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  7. 7

    PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  8. 8

    Included and excluded studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  9. 9

    Characteristics of included studies. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  10. 10

    Extraction data table. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  11. 11

    Flow chart of the study participants. by Milton W. Musaba (8431944)

    Published 2025
    “…Neonatal morbidity was lower: APGAR score <7 at 5 minutes (aPR: 0.36; 95%CI: 0.26–0.50), transfer to postnatal ward with mother (aPR: 9.27; 95%CI: 2.23–38.48), transfer to neonatal unit (aPR: 0.66; 95%CI: 0.56–0.78). …”
  12. 12

    Suggested modifications for the BabySaver. by Milton W. Musaba (8431944)

    Published 2025
    “…Neonatal morbidity was lower: APGAR score <7 at 5 minutes (aPR: 0.36; 95%CI: 0.26–0.50), transfer to postnatal ward with mother (aPR: 9.27; 95%CI: 2.23–38.48), transfer to neonatal unit (aPR: 0.66; 95%CI: 0.56–0.78). …”
  13. 13

    Severity of anaemia status among pregnant women. by Donatus Nbonibe Abaane (15909683)

    Published 2023
    “…At 36 weeks, AIP prevalence was 44.8% (95%CI:39.2, 50.4) using a cut-off of 11.0g/dl. At p<0.05, registering after the first trimester (AOR = 1.87, 95%CI: 1.17, 2.98, P = 0.009) and at a regional hospital (AOR = 2.25, 95%CI: 1.02, 4.98, P = 0.044) were associated with increased odds of AIP but registering at a private hospital (AOR = 0.32, 95%CI: 0.11, 0.92, P = 0.035) was associated with decreased odds of AIP at booking. …”
  14. 14

    Barbie audit data. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  15. 15

    The FEET system of barbie categorisation. by Cylie Williams (3446018)

    Published 2025
    “…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
  16. 16

    DataSheet1_Effect of blueberry intervention on endothelial function: a systematic review and meta-analysis.ZIP by Bixin Deng (18715684)

    Published 2024
    “…However, its effect on endothelial function remains unclear. We conducted a systematic review and meta-analysis to explore the impact of blueberries on endothelial function in adults.…”
  17. 17

    Supplementary Material for: Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study by Sondermeijer L. (7362845)

    Published 2019
    “…With an increasing number of years smoked the risk of melanoma decreased: <20 years: OR = 0.61 (95% CI: 0.46–0.80); 21–40 years: OR = 0.50 (95% CI: 0.37–0.68); >40 years: OR = 0.26 (95% CI: 0.15–0.44). …”
  18. 18
  19. 19

    A randomized controlled trial and prospective cohort investigating antivenom for red-bellied black snake envenomation by Geoffrey K. Isbister (8281572)

    Published 2024
    “…</p> <p>We undertook a multicentre randomized placebo-controlled trial of antivenom for red-bellied black snake bites with patients recruited from the Australian Snakebite Project (July 2014 to June 2020). …”
  20. 20

    Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study by Takamasa Iwakura (798461)

    Published 2020
    “…We analysed data of diabetic-cancer patients treated with high-dose cisplatin (> 50 mg/m<sup>2</sup>)-containing regimens. …”